Cargando…

HbA1c trajectory and cardiovascular outcomes: an analysis of data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study

BACKGROUND: We investigated the associations between glycated hemoglobin (HbA1c) trajectories and cardiovascular outcomes using data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study. METHODS: We used HbA1c values within the first 2 years of treatment for modeling with a late...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun-Sing, Liu, Wei-Ju, Lee, Chia-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239983/ https://www.ncbi.nlm.nih.gov/pubmed/34249303 http://dx.doi.org/10.1177/20406223211026391

Ejemplares similares

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
por: Pei, Junyu, et al.
Publicado: (2023)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
por: Kurukulasuriya, L Romayne, et al.
Publicado: (2010)

Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes
por: Pinhas-Hamiel, Orit, et al.
Publicado: (2014)

Longitudinal HbA(1c) trajectory modelling reveals the association of HbA(1c) and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus
por: Tee, Clarence, et al.
Publicado: (2023)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study
por: Tan, Joshua Kuan, et al.
Publicado: (2023)

Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
por: Hernandez, Domingo, et al.
Publicado: (2013)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

HbA(1c) and the Risks for All-Cause and Cardiovascular Mortality in the General Japanese Population: NIPPON DATA90
por: Sakurai, Masaru, et al.
Publicado: (2013)

Association of Diabetes and HbA(1c) Levels With Gastrointestinal Manifestations
por: Tseng, Ping-Huei, et al.
Publicado: (2012)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
por: Yang, Yeoree, et al.
Publicado: (2018)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study
por: Mongraw-Chaffin, Morgana, et al.
Publicado: (2019)

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
por: Ali, Amar, et al.
Publicado: (2019)

Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
por: Mottalib, Adham, et al.
Publicado: (2018)

Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature
por: Sturm, Gisela, et al.
Publicado: (2011)

Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2011)

The relationship between HbA1c and cardiovascular events in diabetic patients with coronary angioplasty: A cross-sectional study
por: Adel, Seyed Mohammad Hassan, et al.
Publicado: (2022)

Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease
por: Yoshida, Yilin, et al.
Publicado: (2023)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

The association between maternal HbA1c and adverse outcomes in gestational diabetes
por: Muhuza, Marie Parfaite Uwimana, et al.
Publicado: (2023)

The Association of Depression and the Cardiovascular Risk Factors of Blood Pressure, HbA1c, and Body Mass Index among Patients with Diabetes: Results from the Translating Research into Action for Diabetes Study
por: Kimbro, Lindsay B., et al.
Publicado: (2012)

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
por: Ali, Amar, et al.
Publicado: (2019)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis
por: Kim, Hyunah, et al.
Publicado: (2022)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Beyond HbA(1c): Environmental Risk Factors for Diabetic Retinopathy
por: Nwanyanwu, Kristen Harris, et al.
Publicado: (2015)

Diagnostic Testing for Diabetes Using HbA(1c) in the Abu Dhabi Population: Weqaya: the Abu Dhabi Cardiovascular Screening Program
por: Hajat, Cother, et al.
Publicado: (2011)

The Association between HbA1c and Cardiovascular Disease Markers in a Remote Indigenous Australian Community with and without Diagnosed Diabetes
por: Arnold, Luke W., et al.
Publicado: (2016)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5jjo5ta01kdpo4ndpt458b1rme